What is eosinophilia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Eosinophilia?

Eosinophilia is defined as a peripheral blood eosinophil count greater than 0.45 × 10^9/L (450 cells/μL), representing an elevated absolute number of eosinophilic leukocytes in the blood. 1

Classification by Severity

Eosinophilia is stratified into three categories based on absolute eosinophil count:

  • Mild eosinophilia: 500-1,500 cells/μL 2
  • Moderate eosinophilia: 1,500-5,000 cells/μL 2
  • Severe eosinophilia: >5,000 cells/μL 2

Hypereosinophilia: A Distinct Entity

Hypereosinophilia (HE) is defined as a persistent elevated eosinophil count >1.5 × 10^9/L in blood on two examinations at least one month apart and/or tissue hypereosinophilia. 1, 3

Classification of Hypereosinophilia

The National Comprehensive Cancer Network classifies HE into four variant types 1, 3:

  • Hereditary (familial) HE: Characterized by familial clustering without signs of hereditary immunodeficiency 3
  • Primary (clonal/neoplastic) HE: Neoplastic proliferation of eosinophils associated with WHO-defined myeloid and/or lymphoid neoplasms 3
  • Secondary (reactive) HE: Non-clonal eosinophils driven by underlying conditions, typically cytokine-mediated (particularly IL-5) 3
  • HE of undetermined significance (HE-US): No underlying cause identified and no family history 3

Common Causes

The causes can be summarized by the acronym "APLV" 2:

  • Allergic disorders: Including asthma, eczema, and hay fever; typically associated with mild eosinophilia 1, 2
  • Parasitic infections: Helminth infections are the most common identifiable cause in returning travelers (diagnosis rates 19-80%) 1, 4
  • Leukemia/Lymphomas: Values >20,000 cells/μL are highly suggestive for myeloproliferative disorders 2
  • Vasculitis-Immunodeficiency diseases: Including eosinophilic granulomatosis with polyangiitis 5

Important Non-Infectious Causes

Medications are among the most common non-infectious causes, including NSAIDs, beta-lactam antibiotics, and nitrofurantoin. 1, 4

Clinical Significance and Organ Damage

Even mild persistent eosinophilia can cause end-organ damage if left untreated. 1, 4 Eosinophils may directly damage organs through release of granule products, lipid mediators, and cytokines 2:

  • Cardiac involvement: Endomyocardial fibrosis 6
  • Pulmonary involvement: Lung infiltration 2
  • Cutaneous involvement: Skin manifestations 2
  • Gastrointestinal involvement: Eosinophilic gastroenteritis 7
  • Neurologic involvement: Central and peripheral nervous system damage 7

Hypereosinophilic Syndrome (HES)

HES refers to any hypereosinophilia variant with evidence of eosinophil-induced tissue/organ damage. 3 Idiopathic HES is diagnosed when hypereosinophilia with associated organ damage is detected with no apparent underlying disease 3.

Critical Pitfalls

  • Strongyloides stercoralis infection can persist lifelong and later present as hyperinfection syndrome with high mortality in immunocompromised patients. 1 This requires specific attention in patients with travel history to endemic areas.
  • Testing for eosinophilia alone is not an adequate screening strategy for helminth infection, as many people with helminth infections do not have eosinophilia. 4
  • Patients with eosinophilia ≥1.5 × 10^9/L for more than 3 months without evidence of end-organ damage should be referred to a hematologist after exclusion of infectious causes. 1, 3

References

Guideline

Eosinophilia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypereosinophilia Definition and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Eosinophilia Management Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Differential diagnosis of hypereosinophilia].

Zeitschrift fur Rheumatologie, 2019

Research

Eosinophilia: a pragmatic approach to diagnosis and treatment.

Hematology. American Society of Hematology. Education Program, 2015

Research

Hypereosinophilic syndromes.

Orphanet journal of rare diseases, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.